Statistics

Total Visits

Views
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis64

Select a period of time:

Number of views in the range

Views
AVALUZ study: First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER-2 negative recurrent or metastatic BC: PFS analysis29

Views

Views
July 202519
August 20250
September 20254
October 20253
November 20251
December 20252
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil14
United States6
United Kingdom3
Argentina2
Guyana1
Kenya1
Paraguay1
Venezuela1
 

Top cities views

Views
Moses Lake2
Alegrete1
Ashburn1
Asunción1
Atlanta1
Betim1
Camaquã1
Campinas1
Cuiabá1
Franklin1